OBJECTIVES Stroke incidence after transcatheter aortic valve implantation (TAVI) still represents a concern. This multicentre study aimed at investigating the hypothesis that CHADS2 and CHA2DS2-VASc scores may be used to predict perioperative stroke after TAVI. METHODS The Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) is a multicentre, prospective registry of patients undergoing balloon-expandable TAVI using Edwards Sapien and Sapien XT prosthesis between 2007 and 2012. The primary end-point of this study was the 30-day stroke rate. Secondary safety end-points were all the major adverse events based on Valve Academic Research Consortium (VARC-2) criteria. RESULTS One thousand nine hundred and four patients were enrolled in the registry. Mean age was 81.6 ± 6.2 years and 1147 (60.2%) patients were female; mean CHADS2 and CHA2DS2-VASc scores were 2.2 ± 0.8 and 4.4 ± 1.1, respectively. Fifty-four (2.8%) patients had a stroke within 30 days. At multivariable logistic regression analysis, CHA2DS2-VASc (OR: 1.35, 95% CI: 1.03–1.78; P = 0.031) and previous cardiac surgery (OR: 1.96, 95% CI: 1.06–3.6; P = 0.033) but not CHADS2 (OR: 1.05, 95% CI: 0.76–1.44; P = 0.77) were found to be independent predictors of in-hospital stroke. A CHA2DS2-VASc score ≥5 was strongly related to the occurrence of in-hospital stroke (OR: 2.51, 95% CI: 1.38–4.57; P= 0.001). However, CHA2DS2-VASc score showed only poor accuracy for in-hospital stroke with a trend for better accuracy when compared with CHADS2 score (area under the curve: 0.61, 95% CI: 0.59–0.63 vs 0.51; 95% CI: 0.49–0.54, respectively, P = 0.092). CONCLUSIONS In TAVI patients, CHA2DS2-VASc provided a strong correlation for in-hospital stroke but with low accuracy. Dedicated scores to properly tailor procedures and preventive strategies are needed.
Predictive ability of the CHADS2 and CHA2DS2-VASc scores for stroke after transcatheter aortic balloon-expandable valve implantation: an Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) sub-analysis / F. Conrotto, F. D’Ascenzo, A. D’Onofrio, M. Agrifoglio, A. Chieffo, M. Cioni, T. Regesta, G. Tarantini, D. Gabbieri, F. Saia, C. Tamburino, F. Ribichinii, D. Cugola, M. Aiello, F. Sanna, A. Iadanza, E. Pompei, M. Stolcova, A. Cappai, A. Minati, M. Cassese, G.L. Martinelli, A. Agostinelli, G. Gerosa, F. Gaita, M. Rinaldi, S. Salizzoni. - In: EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY. - ISSN 1010-7940. - 50:5(2016 Nov), pp. 867-873. [10.1093/ejcts/ezw199]
Predictive ability of the CHADS2 and CHA2DS2-VASc scores for stroke after transcatheter aortic balloon-expandable valve implantation: an Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) sub-analysis
M. Agrifoglio;
2016
Abstract
OBJECTIVES Stroke incidence after transcatheter aortic valve implantation (TAVI) still represents a concern. This multicentre study aimed at investigating the hypothesis that CHADS2 and CHA2DS2-VASc scores may be used to predict perioperative stroke after TAVI. METHODS The Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER) is a multicentre, prospective registry of patients undergoing balloon-expandable TAVI using Edwards Sapien and Sapien XT prosthesis between 2007 and 2012. The primary end-point of this study was the 30-day stroke rate. Secondary safety end-points were all the major adverse events based on Valve Academic Research Consortium (VARC-2) criteria. RESULTS One thousand nine hundred and four patients were enrolled in the registry. Mean age was 81.6 ± 6.2 years and 1147 (60.2%) patients were female; mean CHADS2 and CHA2DS2-VASc scores were 2.2 ± 0.8 and 4.4 ± 1.1, respectively. Fifty-four (2.8%) patients had a stroke within 30 days. At multivariable logistic regression analysis, CHA2DS2-VASc (OR: 1.35, 95% CI: 1.03–1.78; P = 0.031) and previous cardiac surgery (OR: 1.96, 95% CI: 1.06–3.6; P = 0.033) but not CHADS2 (OR: 1.05, 95% CI: 0.76–1.44; P = 0.77) were found to be independent predictors of in-hospital stroke. A CHA2DS2-VASc score ≥5 was strongly related to the occurrence of in-hospital stroke (OR: 2.51, 95% CI: 1.38–4.57; P= 0.001). However, CHA2DS2-VASc score showed only poor accuracy for in-hospital stroke with a trend for better accuracy when compared with CHADS2 score (area under the curve: 0.61, 95% CI: 0.59–0.63 vs 0.51; 95% CI: 0.49–0.54, respectively, P = 0.092). CONCLUSIONS In TAVI patients, CHA2DS2-VASc provided a strong correlation for in-hospital stroke but with low accuracy. Dedicated scores to properly tailor procedures and preventive strategies are needed.| File | Dimensione | Formato | |
|---|---|---|---|
|
ejcts.ezw199.full.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
246.42 kB
Formato
Adobe PDF
|
246.42 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
|
ezw199.pdf
accesso riservato
Tipologia:
Publisher's version/PDF
Dimensione
307.05 kB
Formato
Adobe PDF
|
307.05 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.




